A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT05160584 · RECRUITING
Trial details
- NCT number
- NCT05160584
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-11-18
- Primary completion
- 2028-04-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.